As in colon cancer, immunotherapy proved to be effective in patients with alterations of mismatch repair gene alterations; we could hypothesize that ATM mutations could enhance the genomic instability of DNA and enhance the immunotherapy response in triple-negative BC patients. The gene discussed is ATM; the disease is malignant colon neoplasm.